AG announces agreement over drug marketing
Posted: Thursday, October 23, 2008
PIERRE, S.D. (AP) -- Attorney General Larry Long says an agreement has been reached that resolves a five-year investigation by 33 states concerning Pfizer's (FY'-zers) promotion of the drugs Celebrex and Bextra.
According to Long, the stipulated judgment means South Dakota's share of Pfizer Inc.'s $60 million payment to the states is $589,168.
The investigation began in 2003. Long says it was to determine whether Pfizer and another drug company misrepresented that Celebrex was safer and more effective than traditional nonsteroidal anti-inflammatory drugs such as Advil and Aleve. He says additional concerns were raised about Bextra during the probe.
Among other stipulations, Long says the judgment means Pfizer must submit television drug commercials to the Food and Drug Administration for approval.
According to Long, the stipulated judgment means South Dakota's share of Pfizer Inc.'s $60 million payment to the states is $589,168.
The investigation began in 2003. Long says it was to determine whether Pfizer and another drug company misrepresented that Celebrex was safer and more effective than traditional nonsteroidal anti-inflammatory drugs such as Advil and Aleve. He says additional concerns were raised about Bextra during the probe.
Among other stipulations, Long says the judgment means Pfizer must submit television drug commercials to the Food and Drug Administration for approval.
Story Comments
Read More and Post Comments 0 comment(s)
Please note: The following are comments from readers. In no way do they represent the views of The Sioux City Journal or Lee Enterprises. We will not edit or alter your comments, but we do reserve the right to not post or to remove comments that violate our code of conduct. No comment may contain potentially libelous statements; obscene, explicit or racist language; personal attacks, insults or threats. Terms of Service
